VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $306,000 | +8.9% | 9,550 | 0.0% | 0.07% | -2.9% |
Q3 2021 | $281,000 | -13.5% | 9,550 | 0.0% | 0.07% | -9.2% |
Q2 2021 | $325,000 | +4.8% | 9,550 | 0.0% | 0.08% | -3.8% |
Q1 2021 | $310,000 | -98.1% | 9,550 | -97.9% | 0.08% | -98.2% |
Q4 2020 | $16,678,000 | +120.4% | 463,010 | +139.7% | 4.42% | +90.1% |
Q3 2020 | $7,566,000 | +2067.9% | 193,195 | +1932.6% | 2.32% | +1920.0% |
Q2 2020 | $349,000 | +56.5% | 9,505 | -2.0% | 0.12% | +18.6% |
Q1 2020 | $223,000 | -21.5% | 9,695 | -0.2% | 0.10% | -3.0% |
Q4 2019 | $284,000 | +9.7% | 9,715 | 0.0% | 0.10% | +14.9% |
Q3 2019 | $259,000 | +3.6% | 9,715 | -0.5% | 0.09% | +8.8% |
Q2 2019 | $250,000 | +6.8% | 9,765 | -6.5% | 0.08% | +8.1% |
Q1 2019 | $234,000 | +4.0% | 10,440 | -2.1% | 0.07% | -8.6% |
Q4 2018 | $225,000 | +7.7% | 10,660 | -5.5% | 0.08% | +26.6% |
Q3 2018 | $209,000 | -14.3% | 11,275 | +3.1% | 0.06% | -14.7% |
Q2 2018 | $244,000 | -2.4% | 10,935 | -3.8% | 0.08% | -1.3% |
Q1 2018 | $250,000 | – | 11,365 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |